Who owns APREA THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Aprea Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Aprea Therapeutics stock

Who bought or sold APREA THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
AIGH Capital Management 1.0M $775k 174% Mar 2026
 View chart
Vestal Point Capital 350k $267k 100% Mar 2026
 View chart
Sphera Funds Management 270k $206k 0% Mar 2026
 View chart
Nantahala Capital Management 206k $157k 0% Mar 2026
 View chart
Geode Capital Management 119k $91k 191% Mar 2026
 View chart
Scientech Research 60k $46k 100% Mar 2026
 View chart
Vanguard Group 58k $50k -63% Dec 2025
 View chart
Bnp Paribas Arbitrage, Snc 40k $30k 46% Mar 2026
 View chart
Vanguard Fiduciary Trust 39k $29k 100% Mar 2026
 View chart
XTX Topco 24k $21k 100% Dec 2025
 View chart
Morgan Stanley 22k $17k -71% Mar 2026
 View chart
LPL Financial 21k $16k -19% Mar 2026
 View chart
Vanguard Capital Management 20k $15k 100% Mar 2026
 View chart
HighTower Advisors 14k $11k 0% Mar 2026
 View chart
Two Sigma Securities 14k $10k 100% Mar 2026
 View chart
BlackRock 8.5k $6.5k 0% Mar 2026
 View chart
Tower Research Capital 7.8k $6.7k 1278% Dec 2025
 View chart
UBS Group 2.2k $1.6k -13% Mar 2026
 View chart
Group One Trading 577.00 $440.020200 0% Mar 2026
 View chart
Advisor Group Holdings 300.00 $255.000000 -25% Dec 2025
 View chart
WealthCollab 158.00 $120.996400 0% Mar 2026
 View chart
SBI Securities 16.00 $12.000000 7% Mar 2026
 View chart

Who sold out of Aprea Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Murchinson Dec 2025 340k $290k
DRW Holdings Dec 2025 121k $103k
Sio Capital Management Sep 2025 112k $166k
Citadel Advisors Dec 2025 51k $44k
Jane Street Dec 2025 47k $40k